The ADAPTABLE Study might be completed, but DCRI’s learnings & secondary analyses are not. Read a Q&A w/ DCRI Exec Dir Adrian “WE NEED RCTS!” Hernandez to learn about how the demonstration project for PCORnetwork creates a launch pad for future #clinicalresearch with #EHRs : bit.ly/2RweFb2

'We chose outcomes that were important to patients and clinicians alike,' DCRI's Schuyler Jones says while sharing additional insights on ADAPTABLE Study during an #ACC21 deep dive.

My favorite part of the journey was collaborating and learning from our amazing ADAPTORS. I have such deep respect and love for each one of them. J Greg Merritt, PhD Madelaine Faulkner Tom, Linda, Desiree, Nadine, Kevin, Henry, Jacqueline, Ken, & Bill ❤️ THANK YOU!

Great job by Schuyler Jones on behalf of the ADAPTABLE Study team, including patient partners. Lot to reflect upon here: #ASA dosing, tolerability, new #RCT methods, use of #EHR to perform research PCORnetwork #ACC21

This is the FIRST TIME we have had a participant in a trial present the background for why the study was done and the primary results!

Congratulations to Schuyler Jones and the ADAPTABLE Study team for bringing this trial to completion!

Proud to say that Schuyler started his career Durham VA Health Care System.

Adrian “WE NEED RCTS!” Hernandez Manesh Patel Duke Clinical Research Institute Duke Cardiology

#ACC21 American College of Cardiology Sharing What We Learned | The Patient-Centered Outcomes Research Institute-funded #ADAPTABLEstudy team led by Duke Clinical Research Institute is committed to sharing results with participants. Read our #plainlanguage summary & watch a Town Hall recording featuring patient partners at theaspirinstudy.org PCORnetwork

Big day for #patientengagement and #Decentralizedtrials PCORnetwork !! Holly Robertson amber sharlow Deb Ty Rorick Lisa Eskenazi

Can't wait to hear the results of the large PCORnetwork trial!

We are proud to be apart of this novel type of pragmatic research EssentiaHealth

NicoleWorden Jason Schultz K Bishu Schuyler Jones amber sharlow

Funded by The Patient-Centered Outcomes Research Institute the #ADAPTABLEstudy is a large-scale study of aspirin dosing embedded in real-world practice and the first #randomizedcontrolledtrial using PCORnetwork. Learn results at American College of Cardiology on 5/15, 9:00 am. #ACC21 Duke Clinical Research Institute

Looking forward to seeing/hearing the public discussions on ADAPTABLE Study at #ACC21 . We learned about aspirin dosing but also about what's possible (and not) in a large pragmatic trial. #evidencematters

#ACC21 begins one month from today! We are excited to be presenting results from ADAPTABLE Study, CONNECT-HF, the Coalition ACTION trial, and more. Stay up to date on DCRI's American College of Cardiology involvement: bit.ly/2OQD35Q

American College of Cardiology Douglas Drachman Excited for our #ADAPTABLE Community -- results of aspirin dosing in patients with established cardiovascular disease on May 15. Adrian “WE NEED RCTS!” Hernandez Robert Harrington Holly Robertson Matthew Roe amber sharlow Duke Clinical Research Institute

The Duke Clinical Research Institute ADAPTABLE Study has led the way in demonstrating the value of #patientcentered #PCTs #virtualtrials . Looking forward to the results in 2021! Schuyler Jones amber sharlow Adrian “WE NEED RCTS!” Hernandez Henry Cruz J Greg Merritt, PhD

Exciting partnership with health plans to link #RWE data in the ADAPTABLE Study! Kevin Haynes J Greg Merritt, PhD Henry Cruz Schuyler Jones Adrian “WE NEED RCTS!” Hernandez amber sharlow K Gregoir Duke Clinical Research Institute

Incorporating pragmatism in clinical research--excited about the way research is moving!

Check out our report of the rationale and methods of the #ADAPTABLE trial in JAMA Cardiology , an innovative #pragmatic , #patient -oriented, #technology -enabled #RCT aiming to find the right dose of #aspirin in 2ry #prevention of #ASCVD

jamanetwork.com/journals/jamac…

Stay tuned to this channel and visit theaspirinstudy.org as we continue to collaborate with patient partners, investigators, and clinicians on concluding the study and sharing what we learned.

Yes, this. 🙌🏻

Yes this, let’s make it better!!